Chronic cough, defined as a cough lasting more than eight weeks, presents a common yet challenging issue in clinical practice. Despite its prevalence, the etiology often remains elusive, leading to diagnostic dilemmas and management difficulties.
Traditionally, chronic cough has been attributed to postnasal drip syndrome, gastroesophageal reflux disease, and asthma. However, recent studies have highlighted the role of atypical presentations, including eosinophilic bronchitis and non-acid reflux. Moreover, the concept of cough hypersensitivity syndrome is gaining traction, emphasizing the role of neurogenic inflammation and peripheral sensitization in the pathophysiology of chronic cough.
Given the multifactorial nature of chronic cough, a systematic and comprehensive approach is crucial. A thorough history and physical examination can provide valuable clues. Additionally, objective tests such as spirometry, chest radiography, and upper airway endoscopy can help in identifying the underlying condition. More advanced investigations like bronchoscopy, esophageal manometry, and 24-hour pH monitoring may be warranted in refractory cases.
Treatment should be tailored according to the identified etiology. Empirical therapy based on the most common causes may provide relief in many cases. However, refractory cases may require a more targeted approach, including inhaled corticosteroids, proton pump inhibitors, or neuromodulators. Recent advances include the use of novel antitussive drugs targeting neuronal pathways, providing promising results in clinical trials.
In conclusion, chronic cough requires a comprehensive approach for effective diagnosis and management. Understanding the evolving concepts in etiology and pathophysiology, coupled with a systematic diagnostic approach and targeted treatment strategies, can enhance patient outcomes and reduce the burden of this common condition. As our understanding of chronic cough continues to expand, it is hoped that more effective and tailored treatment strategies will emerge.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation